Literature DB >> 10434811

Effect-site modelling of propofol using auditory evoked potentials.

M White1, M J Schenkels, F H Engbers, A Vletter, A G Burm, J G Bovill, G N Kenny.   

Abstract

Auditory evoked potentials (AEP) were used to monitor central nervous system effects during induction and recovery from anaesthesia produced by infusion of propofol 30 mg kg-1 h-1 in 22 healthy male patients. Non-parametric and parametric modelling techniques were used successfully to calculate the parameter keo which linked pharmacokinetic with pharmacodynamic aspects of drug action in only 15 of the study patients. In the non-parametric analysis, keo was found to have a mean value of 0.2 (range 0.1-0.36) min-1. Estimation of keo allowed calculation of the effect-site concentration (Ce50) associated with 50% of AEP effect for the population (2.08 micrograms ml-1; 95% confidence limits 1.7-2.45). There were no significant differences between keo values calculated by non-parametric and individual parametric modelling techniques. During recovery, 50% of patients demonstrated evidence of waking at an effect-site concentration of 2.28 micrograms ml-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434811     DOI: 10.1093/bja/82.3.333

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  [Effect compartment equilibration and time-to-peak effect. Importance of a pharmacokinetic-pharmacodynamic principle for the daily clinical practice].

Authors:  J Bruhn; P M Schumacher; T W Bouillon
Journal:  Anaesthesist       Date:  2005-10       Impact factor: 1.041

2.  Use of target controlled infusion to derive age and gender covariates for propofol clearance.

Authors:  Martin White; Gavin N C Kenny; Stefan Schraag
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

3.  Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening.

Authors:  Hiroko Iwakiri; Noboru Nishihara; Osamu Nagata; Takashi Matsukawa; Makoto Ozaki; Daniel I Sessler
Journal:  Anesth Analg       Date:  2005-01       Impact factor: 6.627

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.